Dr. Yasuhiro Hashimoto

Biography

Dr. Yasuhiro (Yas) Hashimoto is the founder and President of Silicon Valley Tech, Inc., engages in investing and accelerating the U.S. & Japanese startups since 2014. He is also a Medical Advisor for Mavericks (Investment Boutique Firm in Palo Alto) and a Vice Chairman of Japan Academic Society for Genomic Pharmacology. Yas was former Founder, President and CEO of MediBIC Group, a leading public biotechnology company in Japan specializing in biomarker discovery and pharmacogenomics. He also established Asia Private Equity Capital, MediBIC’s Investment division, which specialized in Asian biotech companies. Previously, Yas was Founder and CEO of Genetic Lab in Japan (subsequently acquired by Transgenic Inc.) and a Department Head at Nippon Glaxo. Yas has also been a board member of Strand Genomics in India and prior to joining Glaxo, an executive at Syntex. Earlier in his career, Yas was an Associate Professor at the University of Pennsylvania Medical School, among other faculty appointments. Yas has deep scientific expertise in inflammation and immunology, molecular analysis, diagnostics, regenerative medicine, stem cells, and oncology. He has a deep network of senior relationships in big pharma, biotechs, other R&D based companies, VCs, and financial firms in Japan, Korea, China, Singapore and India. He is the recipient of numerous awards and fellowships. Yas received his medical degree at Osaka University Medical School.

Research Interest

Medicine science, oncology, Molecular Biology, Business management